HOME >> BIOLOGY >> NEWS
Taking the next step toward growing our own fuel

URBANA -- Developing a petroleum-free fuel from corn byproducts is one of the goals of a newly named research theme at the University of Illinois at Urbana-Champaign. Eight research laboratories will pool their expertise, attacking the problems from different directions to improve the efficiency of bioconversion of plant fibers into fuels and other value added products.

The new theme is the seventh to be chosen for the Institute for Genomic Biology under the direction of Harris A. Lewin, Gutgsell Endowed Chair in the department of animal sciences. Although the building housing the IGB will not be completed until 2006, the work that will go on inside already has begun.

Lewin said that the new IGB research theme, led by Hans Blaschek, will address one of the most critical problems facing our nation.

"With crude oil at $50 per barrel, we must examine renewal sources of energy as a viable alternative to fossil fuels," Lewin said. "The vision and experience of Blaschek and his co-workers will be important in setting the national agenda for future research on renewable energy sources. Importantly, the outcomes of this research may have direct benefit to farmers and the agricultural industries of the Midwest. I am proud to have the new theme on Molecular Bioengineering of Biomass Conversion as part of the IGB's research, education and economic development portfolio."

Blaschek is a microbiologist in the College of Agricultural, Consumer and Environmental Sciences. He has been studying microorganisms that are used in fermentation processes for over 20 years. He is striving to overcome the obstacles related to biomass conversion into value-added products.

"The beneficiaries of this research will be agriculture and agriculture-based industries in Illinois," Blaschek said, "but ultimately all of us will benefit as consumers of energy." He believes that renewable fuel made from corn is the direction we need to go in order
'"/>

Contact: Debra Levey Larson
dlarson@uiuc.edu
217-244-2880
University of Illinois at Urbana-Champaign
7-Oct-2004


Page: 1 2

Related biology news :

1. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
2. Taking heart failure to the MAT1
3. Taking chips to the next level of gene hunting
4. Vax and Pax: Taking turns to build an eye
5. Taking evolutions temperature: Researchers pinpoint the energy it takes to make a species
6. Taking a bite out of a fellow worker helps wasps recruit new foragers
7. Taking a break from fractures: A closer look at vitamin D
8. Taking a flying jump
9. Taking the piste out of Alpine vegetation
10. Bursts of waves drive immune system soldiers toward invaders
11. A decisive step toward a cure for insulin dependent diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Taking the next step toward growing our own fuel

(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: